Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation

Nephrology Dialysis Transplantation

Volumn 19, Issue 7, 2004, Pages 1779-1785

  Snanoudj, Renaud ^a,b   Durrbach, Antoine ^a,b   Gauthier, Eric ^a   Adams, David ^a   Samuel, Didier ^c   Ferlicot, Sophie ^a   Bedossa, Pierre ^a   Prigent, Alain ^a   Bismuth, Henri ^c   Charpentier, Bernard ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL PAUL BROUSSE   (France)

Author keywords

Amylosis; Familial amyloid polyneuropathy; Liver transplantation; Renal failure; Survival

Indexed keywords

AMYLOID; CALCINEURIN INHIBITOR; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; OKT 3; TACROLIMUS;

ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; FOLLOW UP; GLOMERULAR DYSFUNCTION; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION TEST; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEINURIA; SURGICAL MORTALITY; TUBULAR DYSFUNCTION; VASCULAR AMYLOIDOSIS; WEIGHT REDUCTION;

ADULT; AMYLOID NEUROPATHIES, FAMILIAL; BIOPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 3242726715     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh063     Document Type: Article

References (20)

1. Costa PP, Figueira AS, Bravo FR. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA 1978; 75: 4499-4503
2. Nakazato M, Sasaki H, Furuya H et al. Biochemical and genetic characterization of type I familial amyloidotic polyneuropathy. Ann Neurol 1987; 21: 596-598
3. Hamilton JA, Steinrauf LK, Liepnieks J et al. Alteration in molecular structure which results in disease: the Met-30 variant of human plasma transthyretin. Biochim Biophys Acta 1992; 1139: 9-16
4. Thylen C, Wahlqvist J, Haettner E, Sandgren O, Holmgren G, Lundgren E. Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. EMBO J 1993; 12: 743-748
5. Adams D, Samuel D, Goulon-Goeau C et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000; 123 [Pt 7]: 1495-1504
6. Hofer PA, Anderson R. Postmortem findings in primary familial amyloidosis with polyneuropathy. Acta Pathol Microbiol Scand A 1975; 83: 309-322
7. Lobato L, Beirao I, Guimaraes SM et al. Familial amyloid polyneuropathy type I (Portuguese): distribution and characterization of renal amyloid deposits. Am J Kidney Dis 1998; 31: 940-946
8. Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994; 235: 479-485
9. Skinner M, Lewis WD, Jones LA et al. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med 1994; 120: 133-134
10. Ericzon BG, Suhr O, Broome U et al. Liver transplantation halts the progress of familial amyloidotic polyneuropathy. Transplant Proc 1995; 27: 1233
11. Rydh A, Suhr O, Hietala SO, Ahlstrom KR, Pepys MB, Hawkins PN. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation. Eur J Nucl Med 1998; 25: 709-713
12. Carvalho MJ, Lobato L, Ventura A et al. Remission of proteinuria following liver transplantation for familial amyloid polyneuropathy TTR met30. Transplant Proc 2000; 32: 2664-2666
13. Yi S, Takahashi K, Naito M et al. Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I. Am J Pathol 1991; 138: 403-412
14. Murakami T, Yi S, Maeda S et al. Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy. Am J Pathol 1992; 141: 451-456
15. Suhr OB, Ando Y, Holmgren G et al. Liver transplantation in familial amyloidotic polyneuropathy (FAP). A comparative study of transplanted and non-transplanted patient's survival. Transplant Int 1998; 11 [Suppl 1]: S160-S163
16. Riedstra S, Ferreira JP, Costa PM. Study of an anti-human transthyretin immunoadsorbent. Influence of coupling chemistry on binding capacity and ligand leakage. J Chromatogr B, Biomed Sci Appl 1998; 705: 213-222
17. Lobato L, Beirao I, Silva M et al. Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy. Nephrol Dial Transplant 2003; 18: 532-538
18. Steen L, Wahlin A, Bjerle P, Holm S. Renal function in familial amyloidosis with polyneuropathy. Acta Med Scand 1982; 212: 233-236
19. Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 1996; 47: 944-951
20. Pomfret EA, Lewis WD, Jenkins RL et al. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 1998; 65: 918-925